Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury

Tetrahydrocurcumin (THC), a principal metabolite of curcumin, was tested in a rat model of type 2 diabetes mellitus. THC was administered via daily oral gavage with the lipid carrier polyenylphosphatidylcholine (PPC) as add‐on therapy to losartan (angiotensin receptor blocker) to examine effects on...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaeli, Mahyar, Nunes, Ane C. F., Zhao, Yitong, Khazaeli, Mahziar, Prudente, John, Vaziri, Nosratola D., Singh, Bhupinder, Lau, Wei Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041385/
https://www.ncbi.nlm.nih.gov/pubmed/36971089
http://dx.doi.org/10.1002/prp2.1079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041385/
https://www.ncbi.nlm.nih.gov/pubmed/36971089
http://dx.doi.org/10.1002/prp2.1079

Ejemplares similares